Posted on 2/25/21
Concert Pharmaceuticals Reports 2020 Financial Results and Provides Update on Clinical Programs
LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the year ended December 31, 2020, and provided an update on its product pipeline.“As . . .
Posted on 2/25/21
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported . . .
Posted on 2/25/21
Acushnet Holdings Corp. Announces Fourth Quarter and Full Year 2020 Financial Results
FAIRHAVEN, Mass.--(BUSINESS WIRE)--Acushnet Holdings Corp. (NYSE:GOLF) published its fourth quarter and full year 2020 financial results on February 25, 2021. The results are available via the . . .
Posted on 2/25/21
Karuna Therapeutics Reports Fourth Quarter and Year End 2020 Financial Results and Provides General Business Update
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today . . .
Posted on 2/25/21
Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results
PARSIPPANY, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health . . .
Posted on 2/25/21
Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare pediatric liver disease company developing novel bile acid modulators, today provided . . .
Posted on 2/25/21
Agios Reports Fourth Quarter and Full Year 2020 Financial Results
CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and genetically . . .
Posted on 2/25/21
MTBC Reports Record Full Year 2020 Results
SOMERSET, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of proprietary, cloud-based healthcare IT solutions and services, today announced . . .
Posted on 2/25/21
Radius Health Fourth Quarter and Full Year Results
BOSTON, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), today reported its financial results for the fourth quarter ended December 31, 2020 as . . .
Posted on 2/25/21
Altimmune Announces Financial Results for the Year Ended December 31, 2020 and Provides a Corporate Update
GAITHERSBURG, Md., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the year ended December 31, . . .
Posted on 2/25/21
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
WAYNE, Pa., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, . . .
Posted on 2/25/21
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central . . .
Posted on 2/25/21
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results
CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both . . .
Posted on 2/25/21
DLA Piper Advises Truvian Sciences in Oversubscribed $105 Million Series C
DLA Piper represented Truvian Sciences in its recent oversubscribed US$105 million Series C financing. The round was led by TYH Ventures, Glen Tullman of 7wireVentures and . . .
Posted on 2/25/21
Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update
CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today reported business highlights and financial results for . . .
Posted on 2/25/21
Cyclerion Therapeutics Reports Full Year 2020 Financial Results and Corporate Update
CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive . . .
Posted on 2/25/21
BioCryst Reports Fourth Quarter and Full Year 2020 Financial Results
RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced financial results for the fourth quarter and full year ended . . .
Posted on 2/25/21
Chimerix Reports Fourth Quarter and Year End 2020 Financial Results and Provides Operational Update
DURHAM, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious . . .
Posted on 2/25/21
Novan Reports Full Year 2020 Financial Results and Provides Corporate Update
MORRISVILLE, N.C., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (Nasdaq: NOVN), today announced its financial and operating results for the year ended December 31, 2020 and . . .
Posted on 2/25/21
COVID Restrictions To Be Loosened Monday; More Vaccine Sites Coming Soon
As more pharmacies across the state receive vaccine doses from the federal government and the number of COVID-19 cases declines, Gov. Ralph Northam said Wednesday he . . .
Posted on 2/25/21
Merck to Acquire Pandion Therapeutics
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. (Nasdaq: PAND) today announced that the companies have entered into
Posted on 2/25/21
Madrigal Pharmaceuticals Reports 2020 Fourth Quarter and Full Year Financial Results and Highlights
WEST CONSHOHOCKEN, Pa., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its fourth quarter and full year 2020 financial results and highlights.“We . . .
Posted on 2/25/21
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Business Highlights
STAMFORD, Conn., Feb. 25, 2021 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe . . .
Posted on 2/25/21
Jounce Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results
CAMBRIDGE, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies . . .
Posted on 2/25/21
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter and year ended December . . .
